Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: Low incidence of CNS tumours

Pediatric Blood and Cancer

Volumn 57, Issue 1, 2011, Pages 119-125

  Renard, Marleen ^a   Suciu, Stefan ^b   Bertrand, Yves ^c   Uyttebroeck, Anne ^a   Ferster, Alice ^d   van der Werff ten Bosch, Jutte ^e   Mazingue, Françoise ^f   Plouvier, Emannuel ^g   Robert, Alain ^h   Boutard, Patrick ⁱ   Millot, Frédéric ^j   Munzer, Martine ^k   Mechinaud, Françoise ^l   Lescoeur, Brigitte ^m   Baila, Liliana ^b   Vandecruys, Els ⁿ   Benoit, Yves ⁿ   Philippet, Pierre ^o  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b EORTC DATA CENTER   (Belgium)

^c HÔPITAL DEBROUSSE   (France)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^e UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^f CHR   (France)

^g UNIVERSITY HOSPITAL OF BESANÇON   (France)

^h HÔPITAL DES ENFANTS   (France)

ⁱ CAEN UNIVERSITY HOSPITAL   (France)

^j University of Poitiers   (France)

^k AMERICAN HOSPITAL OF PARIS   (France)

^l HÔTEL DIEU   (France)

^m HÔPITAL ROBERT DEBRÉ   (France)

ⁿ GHENT UNIVERSITY HOSPITAL   (Belgium)

^o NONE   (Belgium)

more..

Author keywords

Acute myeloblastic leukaemia; Central nervous system tumour; Childhood lymphoblastic leukaemia; Childhood lymphoblastic lymphoma; Second neoplasm

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BRAIN TUMOR; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER REGRESSION; CANCER SURVIVAL; CARCINOMATOSIS; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CLINICAL PROTOCOL; CUTANEOUS HISTIOCYTOSIS; EWING SARCOMA; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTIOCYTOSIS; HODGKIN DISEASE; HUMAN; INFANT; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OSTEOSARCOMA; OVERALL SURVIVAL; PERITONEAL CARCINOMATOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SECOND NEOPLASM; SOFT TISSUE SARCOMA; THYROID CANCER; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DAUNORUBICIN; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; MALE; NEOPLASMS, SECOND PRIMARY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; VINCRISTINE;

EID: 79955725990     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23083     Document Type: Article

References (35)

1. Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study. J Clin Oncol 2001; 19: 3163-3172.
2. Mody R, Li S, Dover DC, et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. Blood 2008; 111: 5515-5523.
3. Neglia JP, Meadows AT, Robison LL, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 325: 1330-1336.
4. Nygaard R, Garwicz S, Haldorsen T, et al. Second malignant neoplasms in patients treated for childhood leukemia. A population-based cohort study from the Nordic countries. The Nordic Society of Pediatric Oncology and Hematology (NOPHO). Acta Paediatr Scand 1991; 80: 1220-1228.
5. Walter AW, Hancock ML, Pui CH, et al. Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. J Clin Oncol 1998; 16: 3761-3767.
6. Henze G, Langermann HJ, Bramswig J, et al. The BFM 76/79 acute lymphoblastic leukemia therapy study (author's transl). Klin Padiatr 1981; 193: 145-154.
7. Langermann HJ, Henze G, Wulf M, Riehm H. Estimation of tumor cell mass in childhood acute lymphoblastic leukemia: Prognostic significance and practical application. Klin Padiatr 1982; 194: 209-213.
8. Vilmer E, Suciu S, Ferster A, et al. Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: A CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia 2000; 14: 2257-2266.
9. Duval M, Suciu S, Ferster A, et al. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: Results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial. Blood 2002; 99: 2734-2739.
10. Millot F, Suciu S, Philippe N, et al. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: Results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial. J Clin Oncol 2001; 19: 1935-1942.
11. van der Werff T, Bosch Suciu S, Thyss A, et al. Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: Final results of a randomized phase III trial (58881) of the EORTC CLG. Leukemia 2005; 19: 721-726.
12. Kalbfleisch JD, Prentice RL. The survival analysis of failure time data, 2nd edition. Wiley series in probabilities and statistics, 2nd edition. New-Jersey, USA: Wiley INter-Science; 2002.
13. Bhatia S, Sather HN, Pabustan OB, et al. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 2002; 99: 4257-4264.
14. Dalton VMK, Gelber RD, Li F, et al. Second malignancies in patients treated for childhood acute lymphoblastic leukemia. J Clin Oncol 1998; 16: 2848-2853.
15. Kamps WA, Bokkerink JP, Hahlen K, et al. Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: Results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991). Blood 1999; 94: 1226-1236.
16. Loning L, Zimmermann M, Reiter A, et al. Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: Significantly lower risk without cranial radiotherapy. Blood 2000; 95: 2770-2775.
17. de Vathaire F, Francois P, Hill C, et al. Role of radiotherapy and chemotherapy in the risk of second malignant neoplasms after cancer in childhood. Br J Cancer 1989; 59: 792-796.
18. Pui CH, Pei D, Sandlund JT, et al. Long-term results of St Jude Total Therapy Studies 11, 12 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia 2010; 24: 371-382.
19. Relling MV, Rubnitz JE, Rivera GK, et al. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 1999; 354: 34-39.
20. Rimm IJ, Li FC, Tarbell NJ, Winston KR, Sallan SE. Brain tumors after cranial irradiation for childhood acute lymphoblastic leukemia. A 13-year experience from the Dana-Farber Cancer Institute and the Children's Hospital. Cancer 1987; 59: 1506-1508.
21. Tucker MA, D'Angio GJ, Boice JD Jr., et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 1987; 317: 588-593.
22. Robison LL, Bhatia S. Late-effects among survivors of leukaemia and lymphoma during childhood and adolescence. Br J Haematol 2003; 122: 345-359.
23. Tucker MA, Jones PH, Boice JD Jr., et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res 1991; 51: 2885-2888.
24. Hijiya N, Hudson MM, Lensing S, et al. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA 2007; 297: 1207-1215.
25. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009; 360: 2730-2741.
26. Pui CH, Cheng C, Leung W, et al. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 2003; 349: 640-649.
27. Westermeier T, Kaatsch P, Schoetzau A, Michaelis J. Multiple primary neoplasms in childhood: Data from the German Children's Cancer Registry. Eur J Cancer 1998; 34: 687-693.
28. Hawkins MM, Wilson LM, Stovall MA, et al. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. Br Med J 1992; 304: 951-958.
29. Pui CH, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991; 325: 1682-1687.
30. Whitlock JA, Greer JP, Lukens JN. Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia. Cancer 1991; 68: 600-604.
31. Winick NJ, McKenna RW, Shuster JJ, et al. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol 1993; 11: 209-217.
32. Hijiya N, Ness KK, Ribeiro RC, Hudson MM. Acute leukemia as a secondary malignancy in children and adolescents: Current findings and issues. Cancer 2009; 115: 23-35.
33. Thomsen J, Schroder H, Kristinsson J, et al. Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells. Cancer 1999; 86: 1080-1086.
34. Schmiegelow K, Al Modhwahi I, Andersen MK, et al. Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: Results from the NOPHO ALL-92 study. Blood 2009; 113: 6077-6084.
35. Kruger S, Kinzel M, Walldorf C, et al. Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1. Eur J Hum Genet 2008; 16: 62-72.